FDA Drug Application (021178) for GLUCOVANCE by BRISTOL MYERS SQUIBB

Back to FDA Applications sponsored by BRISTOL MYERS SQUIBB

Application Number021178
Product Number001
FormTABLET;ORAL
Dosage1.25MG;250MG **Federal Register determination that product was not discontinued or withdrawn for safety or efficacy reasons**
Product Market Status Discontinued
Therapeutic Equivalence Evaluation Code
Reference Drug
Drug NameGLUCOVANCE
Active IngredientGLYBURIDE; METFORMIN HYDROCHLORIDE

Active IngredientCount
List of drugs with Active Ingredient GLYBURIDE7
List of drugs with Active Ingredient METFORMIN HYDROCHLORIDE32


Back to FDA Applications sponsored by BRISTOL MYERS SQUIBB